Cancer Genetics Inc. (CGIX) Tumbled -14.88% or -0.05 To Price $0.3 On Thursday


Cancer Genetics Inc. (CGIX) tumbled -14.88% or -0.05 to $0.3. It is nearly 9.76 million shares traded, which is 752.54% compare to the average total volume 1.30 million. The market cap of CGIX is $8.27 million. The year to date change is 25.16%. The 52 week price range is from $0.2 to $2.2. Price of CGIX have changed 31.42% during last week. It have changed 72.89% over last month, -61.14% over last 3 months, -61.53% over last 6 months and -83.33% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CGIX is 0.44. It is 46.67% above current price. The 200-day Moving Averages for CGIX is 0.88. It is 193.33% above current price. The 52-week High is 2.2. It is 633.33% from the current price. The 52-week Low is 0.2. It is -33.33% from current price.

There are some statistics of CGIX. It is has market cap $8.27 million. The share outstanding is 27.75 million. The average volume is 1.30 million. The percent of top 15 Institution holding is 15.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CGIX is -122.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CGIX is -52.54%.


Tags:

Share this post